OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis
- 26 September 2022
- journal article
- research article
- Published by Springer Nature in Cellular Oncology
- Vol. 45 (6) , 1255-1275
Abstract
Purpose Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer. As yet, chemotherapy with drugs such as doxorubicin is the main treatment strategy. However, drug resistance and dose-dependent toxicities restrict their clinical use. Natural products are major sources of anti-tumor drugs. OSW-1 is a natural compound with strong anti-cancer effects in several types of cancer, but its effects on the efficacy of chemotherapy in TNBC and its underlying mechanism remain unclear. Methods The inhibitory activities of OSW-1 and its combination with several chemotherapy drugs were tested using in vitro assays and in vivo subcutaneous and metastatic mouse TNBC models. The effects of the mono- and combination treatments on TNBC cell viability, apoptosis, autophagy and related signaling pathways were assessed using MTT, flow cytometry, RNA sequencing and immunology-based assays. In addition, the in vivo inhibitory effects of OSW-1 and (combined) chemotherapies were evaluated in subcutaneous and metastatic mouse tumor models. Results We found that OSW-1 induces Ca2+-dependent mitochondria-dependent intrinsic apoptosis and cyto-protective autophagy through the PI3K-Akt-mTOR pathway in TNBC cells in vitro. We also found that OSW-1 and doxorubicin exhibited strong synergistic anti-TNBC capabilities both in vivo and in vitro. Combination treatment strongly inhibited spontaneous and experimental lung metastases in 4T1 mouse models. In addition, the combination strategy of OSW-1 + Carboplatin + Docetaxel showed an excellent anti-metastatic effect in vivo. Conclusions Our data revealed the mode of action and molecular mechanism underlying the effect of OSW-1 against TNBC, and provided a useful guidance for improving the sensitivity of TNBC cells to conventional chemotherapeutic drugs, which warrants further investigation.Keywords
This publication has 75 references indexed in Scilit:
- Effect of OSW-1 on microRNA expression profiles of hepatoma cells and functions of novel microRNAsMolecular Medicine Reports, 2013
- Mechanisms of Action of Bcl-2 Family ProteinsCold Spring Harbor Perspectives in Biology, 2013
- Amelioration of Doxorubicin-Induced Cardiotoxicity by an Anticancer-Antioxidant Dual-Function Compound, HO-3867The Journal of Pharmacology and Experimental Therapeutics, 2011
- Natural products reveal cancer cell dependence on oxysterol-binding proteinsNature Chemical Biology, 2011
- Synthesis and Biological Activity of 22-Deoxo-23-oxa Analogues of Saponin OSW-1Journal of Medicinal Chemistry, 2011
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- OSW-1: a Natural Compound With Potent Anticancer Activity and a Novel Mechanism of ActionJNCI: Journal of the National Cancer Institute, 2005
- Toxic proteins released from mitochondria in cell deathOncogene, 2004
- The Bcl-2 family: roles in cell survival and oncogenesisOncogene, 2003
- IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 2002